STRENSIQ 80 mg/.8mL (Asfotase Alfa SOLUTION) 80 mg/.8mL

STRENSIQ 80 mg/.8mL is a subcutaneous solution containing asfotase alfa, used for enzyme replacement therapy. This medication is designed to address specific metabolic conditions, offering targeted support for those in need.

Strength

80 mg/.8mL

Pack Size

12 VIAL in 1 CARTON (25682-019-12) / .8 mL in 1 VIAL (25682-019-01)

Manufacturer / TM Owner

Alexion Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

STRENSIQ 80 mg/.8mL is primarily used for enzyme replacement therapy. It is indicated for conditions related to hypophosphatasia, a rare metabolic disorder. The solution helps to replenish enzyme activity, supporting bone health and overall metabolic function. Patients often seek information on what is STRENSIQ used for, and it is commonly prescribed for managing symptoms associated with this condition.

Side Effects

Common effects of STRENSIQ 80 mg/.8mL may include reactions at the injection site, such as redness, swelling, or itching. Some individuals might experience fatigue or mild gastrointestinal discomfort. These effects are generally mild and temporary, but any persistent or severe reactions should be discussed with a healthcare provider.

Precautions & Warnings

STRENSIQ 80 mg/.8mL should be handled with care, ensuring proper storage and administration techniques. It is important to follow the prescribed guidelines for subcutaneous injection to minimize the risk of infection or irritation. Patients should be aware of any allergic reactions and seek medical advice if necessary.

Avoid Interactions

STRENSIQ 80 mg/.8mL may interact with other medications, particularly those that affect the immune system or metabolism. It is advisable to inform healthcare providers about all current medications to avoid potential interactions. Alcohol and certain supplements might also influence the effectiveness of the treatment.

Frequently Asked Questions

STRENSIQ is used for enzyme replacement therapy in conditions like hypophosphatasia, supporting bone health and metabolic function.

STRENSIQ is administered subcutaneously, typically via injection, following the prescribed guidelines for proper administration.

Common side effects may include injection site reactions, fatigue, and mild gastrointestinal discomfort.

STRENSIQ may interact with other medications, so it is important to consult a healthcare provider before combining treatments.

STRENSIQ should be stored according to the manufacturer's instructions to maintain its efficacy and safety.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.